Novo Nordisk A/S Statistics
NYSE: NVOHealth CareBiotechnology: Pharmaceutical PreparationsUSD
37.69-0.5701 (-1.49%)
Market open · Delayed 15 min · as of Oct 8, 9:55 AM ET
Novo Nordisk A/S by the numbers
Novo Nordisk A/S has a market capitalization of $166.38 billion based on 3.34B shares outstanding. Its trailing P/E ratio is 9.2, below the 8-company peer median of 22.4, and its forward P/E is 11.3. The stock trades 14.3% below its 50-day average and 17.2% below its 200-day average.
Average daily trading volume is 12.54M shares, or about $472.6 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
NVO valuation vs. peer median
| Metric | NVO | Peer median | Difference |
|---|---|---|---|
| Market cap | $166.38B | $124.78B | +33% |
| P/E (TTM) | 9.2 | 22.4 | -59% |
| Forward P/E | 11.3 | 10.8 | +5% |
| Dividend yield | 31.04% | 2.51% | +1137% |
| Avg. volume | 12.54M | 3.59M | +249% |
Peer median across 8 companies: ABT, PFE, VRTX, BMY, SNY, GSK, AZN, REGN.
Valuation
- Market cap
- $166.38B
- P/E (TTM)
- 9.22
- Forward P/E
- 11.33
- EPS (TTM)
- $4.09
- Shares outstanding
- 3.34B
Price and trading
- Previous close
- 38.26
- Open
- 37.80
- Day range
- 37.54 – 37.81
- 52-week range
- 35.12 – 64.16
- 52-week change
- -35.17%
- Beta
- —
- Volume
- 1.33M
- Average volume
- 12.54M
Dividends and events
- Annual dividend
- $11.70
- Dividend yield
- 31.04%
- Next earnings date
- Nov 4, 2026
Additional statistics
- Market Cap
- 166.38B
- Pe
- 9.22
- Forward Pe
- 11.33
- Eps
- 4.09
- Dividend Yield
- 4.70%
- Dividend Rate
- 11.70
- Week52 High
- 64.16
- Week52 Low
- 35.12
- Avg Volume
- 12.54M
- Shares Outstanding
- 3.34B
- Ma50
- 43.96
- Ma200
- 45.50
- Earnings Date
- Nov 4, 2026
- Pct From52w High
- -41.26%
- Pct From52w Low
- 7.32%